Drugs / LNP1892
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02174237 | May → Sep 2014 | — | Lupin Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LNP1892 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02174237 ↗ |
| Modality | Small molecule | — CHEMBL5499497 ↗ |
| Route | Oral | “Multiple Oral Dose” NCT02174237 ↗ |